Sanofi and Bristol-Myers Squibb's Plavix and Aspirin combination approved in the EU
This article was originally published in Scrip
Executive Summary
The EU Commission has approved Sanofi-Aventis and Bristol-Myers Squibb's DuoPlavin (also known as DuoCover; clopidogrel 75mg and acetylsalicylic acid 100mg or 75mg) for the prevention of atherothrombotic events.